Theme · live manifest · live theme JSON
Biotech '25: Neurology, CNS & Rare Disorders
7 tickers · $13.19B total market cap
Group: Biotech
Biotech '25: Neurology, CNS & Rare Disorders tracks 7 publicly listed stocks in this theme: ACOG, MREO, MTSR, RZLT, SUPN, VERA, VYGR. See the constituent table for details.
Constituents
Build 20260520T081747
| Company | Previous Quarter Report Date | Next Expected Report Date | Last Quarter Earnings Move % | Earnings Move % | Intra-Quarter Move % | Since Last Report % | Market cap | Weight |
|---|---|---|---|---|---|---|---|---|
Metsera, Inc.MTSR | 11/12/2025 | — | -0.35% | — | 0.00% | — | $7.43B | 14.2857 |
Supernus Pharmaceuticals, Inc.SUPN | 05/05/2026 (AMC) | 05/05/2026 (AMC) | 4.60% | 5.80% | -11.77% | -7.44% | $2.74B | 14.2857 |
Vera Therapeutics, Inc.VERA | 05/07/2026 (BMO) | 05/07/2026 (BMO) | -2.14% | -1.11% | -10.28% | -8.12% | $2.38B | 14.2857 |
Rezolute, Inc.RZLT | 05/12/2026 (AMC) | 05/12/2026 (AMC) | 5.79% | 5.05% | -14.06% | -6.91% | $296.7M | 14.2857 |
Voyager Therapeutics, Inc.VYGR | 05/07/2026 (BMO) | 05/07/2026 (BMO) | 28.21% | -2.88% | -16.60% | -14.07% | $210.3M | 14.2857 |
Alpha Cognition Inc. Common StockACOG | 05/14/2026 | 05/14/2026 | -4.87% | 1.18% | 11.81% | -3.65% | $90.1M | 14.2857 |
Mereo BioPharma Group plcMREO | 05/12/2026 (BMO) | 05/12/2026 (BMO) | -2.76% | 7.00% | -28.95% | -8.46% | $38.0M | 14.2857 |
| Average | 4.07% | 2.51% | -9.98% | -8.11% | $1.88B | 14.2857 | ||
| Median | -0.35% | 3.11% | -11.77% | -7.78% | $296.7M | 14.2857 | ||
| Std Dev | 10.49% | 3.68% | 11.94% | 3.09% | $2.50B | 0.0% | ||
| Min | -4.87% | -2.88% | -28.95% | -14.07% | $38.0M | 14.2857 | ||
| Max | 28.21% | 7.00% | 11.81% | -3.65% | $7.43B | 14.2857 | ||
| % Positive Tickers | 42.86% | 66.67% | 14.29% | 0.00% |
* Provisional value: before LstRpt% reaches its 2-day post-report lock window (BMO/AMC adjusted), EarningsPerf is calculated from current vs pre-report and then locks to final LstRpt%.